Nonadherence to beta blockers is a big issue with patients post-MI.
Although healthcare organizations have made great strides in boosting prescribing rates for beta blockers in patients who have suffered a myocardial infarction, (MI) data show that patients are not reaping the full value from these life-saving drugs. The problem is poor medication compliance. Experts maintain that providers and healthcare organizations should now turn their attention to this pressing problem.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010349:Patient Compliance; D014481:United States
D000319:Adrenergic beta-Antagonists